In summary, CPP-CAND is a FOXO4-p53 interaction inhibitor that is anticipated to offer cost-effectiveness, high selectivity, and safety compared to previously developed peptide interaction inhibitors
H tr a chiu: Tng cng tim mch, tr no, th lc, chng oxy ha v gim vim
Safety of N-acetylcysteine at high doses in chronic respiratory diseases: a review
Prebiotic compounds cannot be absorbed into the blood because the body does not have the metabolic enzymes to degrade or utilize them
KPV is considered an anti-inflammatory peptide often paired with the other two when inflammation, not just structural damage, is the target
Understanding this distinction is essential for researchers choosing between them or deciding to use both